SCHEMBL20312980

SCHEMBL20312980

CN(Cc1ccccc1B(O)O)Cc1c2ccccc2c(CN(C)Cc2ccccc2B(O)O)c2cc(C=O)ccc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.36
CYP2D6 P10635 4/20 0.36
CYP2C19 P33261 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
TNNI3 P19429 1/20 0.36
TNNT2 P45379 1/20 0.36
TNNC1 P63316 1/20 0.36
HIF1A Q16665 3/20 0.34
CYP2C9 P11712 2/20 0.34
HSD17B10 Q99714 2/20 0.34
KIF11 P52732 2/20 0.34
PTGER4 P35408 2/20 0.33
CYP3A4 P08684 1/20 0.32
LIPG Q9Y5X9 1/20 0.32
TSHR P16473 2/20 0.32
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1839968 0.84 CYP2D6 (0.49) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL976289 0.81 ALDH1A1 (0.39) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL24274700 0.79 CYP2D6 (0.44) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL975690 0.78 KIF11 (0.41) MEN1KMT2AKIF11KDM4EALDH1A1
SCHEMBL21143034 0.78 CYP2D6 (0.42) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL4460221 0.78 CYP2D6 (0.50) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL21579184 0.76 CYP2D6 (0.47) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL14016096 0.76 HPGD (0.45) MEN1KMT2ATSHRKDM4EALDH1A1
SCHEMBL13990680 0.76 CYP2D6 (0.41) CYP1A2CYP2D6CYP2C19MEN1KMT2A
SCHEMBL13600367 0.72 CYP1A2 (0.37) CYP1A2CYP2D6CYP2C19MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180179233-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2018-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180179233-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 CYP1A2 4561/4885CYP2D6 3814/4885CYP2C19 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.